Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

German Cannabis

Increased product efficacy and patient convenience is anticipated through faster onset of drug action, more predictable therapeutic activity and ease of use….
IM Cannabis (IMCC.C) announced its first shipment from its EU-GMP supply partner into Germany yesterday, as well as their three new distribution agreements penned by Adjupharm GmbH, it’s German…
Xphyto and 3a are developing rapid screening tests for COVID-19 and other high-risk pandemic threats, including H1N1 (swine flu) and H5N1 (avian flu), with a specific focus on early…
Xphyto’s test may be ideal to catch the super-spreaders – the infectious carriers blithely attending drumming circles because they feel healthy….
Pharmadrug (BUZZ.C) and Eve & Co (EVE.C) subsidiary, Natural MedCo (NMC), entered into a supply agreement today for bulk and finished EU-GMP (European Union good manufacturing practice) certified medical…
“Visual confirmation of test results (probe activation) was observed in five to seven minutes,” states Xphyto….
Our early coverage of Xphyto reveals the following company trait: Xphyto says, “We’re going to do this” – and then they do it – quickly….
Vektor is now proceeding with process implementation for the manufacture of Rotigotine patches for human clinical studies….
Farmako GmbH, a subsidiary of Agraflora Organics International (AGRA.C), and ZenPharm, subsidiary of Zenabis Global (ZENA.T), joined into a binding supply term sheet, which serves as the basis for…
XPHY owns a German narcotic manufacturer called Vektor Pharma, another subsidiary called Bunker that has all the licenses to study cannabis as a medicine, and it has formed multiple…